The degree of bone marrow infiltration in patients with hairy cell leukemia treated with splenectomy compatible with long-term hematological remission

被引:0
作者
Zák, P
Chrobák, L
Dedic, K
机构
[1] Fac Med, Hradec Kralove, Czech Republic
[2] Univ Hosp, Hradec Kralove, Czech Republic
[3] Charles Univ Prague, Dept Clin Hematol, Prague, Czech Republic
[4] Charles Univ Prague, Fingerland Inst Pathol, Prague, Czech Republic
关键词
hairy cell leukemia; bone marrow infiltration; splenectomy; DBA.44; long-term remission;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To determine the degree of bone marrow infiltration with hairy cells which is compatible with long-term hematological remission in patients treated with splenectomy, we have investigated 7 patients surviving in hematological remission 61 to 255 months (median 184 months) after splenectomy. As hematological remission has been considered absence of hairy cells (HCs) in the peripheral blood, normalization of peripheral blood cell counts (hemoglobin 120 g/l, white cell count 4.0 x 10(9)/l, absolute granulocyte count 1.5 x 10(9)/l, platelet count 100 x 10(9)/l) and absence of lymfadenopathy and any other activity of the disease. For detection of HCs a very sensitive method of immunostaining with monoclonal antibody DBA.44 in our own modification has been used. Low values of sIL-2R which is considered to be a non invasive marker of tumor burden and activity in HCL were in agreement with the opinion that the bone marrow was the only locality of tumor involvement in splenectomized patients. Infiltration up to 20% with HCs (range 4% to 20%,median 10%) was found to be compatible with long-term hematological remission and long-term overall survival. Patient (No 1) with 30% infiltration of bone marrow with HCs, still normal peripheral blood cell counts, but a very high level of sIL-2R represents extraordinary finding which has been discussed in details.
引用
收藏
页码:72 / 75
页数:4
相关论文
共 14 条
[1]   SERUM LEVELS OF SOLUBLE INTERLEUKIN-2 RECEPTOR IN HAIRY-CELL LEUKEMIA - A RELIABLE MARKER OF NEOPLASTIC BULK [J].
AMBROSETTI, A ;
SEMENZATO, G ;
PRIOR, M ;
CHILOSI, M ;
VINANTE, F ;
VINCENZI, C ;
ZANOTTI, R ;
TRENTIN, L ;
PORTUESE, A ;
MENESTRINA, F ;
PERONA, G ;
AGOSTINI, C ;
TODESCHINI, G ;
PIZZOLO, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1989, 73 (02) :181-186
[2]   THE 3RD INTERNATIONAL WORKSHOP ON HAIRY-CELL LEUKEMIA, LAGUNA-NIGUEL, CALIFORNIA, 19-20 OCTOBER 1989 [J].
CATOVSKY, D ;
GOLDE, DW ;
GOLOMB, HM .
BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (03) :378-379
[3]   LEUKEMIC RETICULOENDOTHELIOSIS (HAIRY CELL LEUKEMIA) - DISTINCT CLINICOPATHOLOGICAL ENTITY [J].
CATOVSKY, D ;
PETTIT, JE ;
GALTON, DAG ;
SPIERS, ASD ;
HARRISON, CV .
BRITISH JOURNAL OF HAEMATOLOGY, 1974, 26 (01) :9-&
[4]  
CHROBAK L, 1993, NEOPLASMA, V40, P133
[5]  
Chrobak L, 1996, NEOPLASMA, V43, P321
[6]  
DEDIC K, 1997, 16 EUR C PATH MAASTR, V193, P422
[7]  
FILLEUL B, 1994, LEUKEMIA, V8, P1153
[8]  
FLANDRIN G, 1984, SEMIN ONCOL, V11, P458
[9]   BONE-MARROW ONE-STEP FIXATION-DECALCIFICATION IN LOWY FMA SOLUTION - AN IMMUNOHISTOLOGICAL AND IN-SITU HYBRIDIZATION STUDY [J].
GAULIER, A ;
FOURCADE, C ;
SZEKERES, G ;
PULIK, M .
PATHOLOGY RESEARCH AND PRACTICE, 1994, 190 (12) :1149-1161
[10]  
HOUNIEU H, 1992, AM J CLIN PATHOL, V98, P26